学会誌・出版物

Respiratory Investigation

Award

Comment of Awardees 2024

We are truly honored to receive the Best Paper Award 2024. This achievement would not have been possible without the guidance of enrolled patients and medical staffs, and we are deeply grateful for their support. We will continue to dedicate ourselves to both clinical practice and research, always keeping this gratitude in mind. Our thanks also go to the editors for their invaluable instruction.

Yours sincerely,
Hirono Nishiyama, Tomoko Tajiri
Awardees of Best Paper Award 2024

Best Paper Award

Year Title Authors volume issue
2024 Prevalence and clinical relevance of comorbid pertussis infection in adult patients with asthma: A prospective, cross-sectional study Hirono Nishiyama, Tomoko Tajiri, Ryota Kurokawa, Tatsuro Suzuki, Keima Ito, Yuta Mori,Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Takehiro Uemura,Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura, Akio Niimi 62 5
2023 Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis Yasuhiko Nishioka, Sakae Homma, Takashi Ogura,Seidai Sato, Naoki Arai, Keisuke Tomii, Koichiro Kamio, Susumu Sakamoto, Yasunari Miyazaki, Hiromi Tomioka,Shu Hisata, Tomohiro Handa, Arata Azuma 61 4

Best Citation Award

Year Title Authors volume issue
2024 Atypical pneumonia: Pathophysiology, diagnosis, and treatment Naoyuki Miyashita 60 1
2024 The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia Shinji Teramoto 60 1
2024 Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facility Noriaki Ito, Yoshihiro Kitahara, Kei Miwata, Mafumi Okimoto,Toshiro Takafuta 60 6
2023 Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis Uchida Y., Ikeda S., Sekine A., katano T., Tabata E., Oda T., Okuda R., Kitamura H., Baba T., Komatsu S., Ogura T. 59 1
2023 The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia Teramoto S. 60 1
2023 A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO Chong W.H., Saha B.K., Medarov B.I. 59 6
2023 Mechanisms underlying the sensation of dyspnea Fukushi I., Pokorski M., Okada Y. 59 1
2022 Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells Yamaya M., Nishimura H., Deng X., Sugawara M., Watanabe O., Nomura K., Shimotai Y., Momma H., Ichinose M., Kawase T. 58 3
2022 Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches Glass D.S., Grossfeld D., Renna H.A., Agarwala P., Spiegler P., Kasselman L.J., Glass A.D., DeLeon J., Reiss A.B. 58 5
2022 Role of Nrf2 in the pathogenesis of respiratory diseases Mizumura K., Maruoka S., Shimizu T., Gon Y. 58 1

Outstanding Reviewers

Year Name Institution
2024 Tomoo Kishaba Okinawa Chubu Hospital, Japan
2024 Naoki Iwanaga Nagasaki University Hospital, Japan
2024 Yutaka Ito Nagoya City University Graduate School of Medical Sciences, Japan
2023 Susumu Sato Kyoto University Graduate School of Medicine, Japan
2023 Tomohiro Handa Graduate School of Medicine, Kyoto University, Japan
2023 Atsushi Miyamoto Toranomon Hospital, Japan
2023 Kentaro Nagaoka Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan
2022 Keisuke Tomii Kobe City Medical Center General Hospital, Japan
2022 Tomoo Kishaba Okinawa Chubu Hospital, Japan
2022 Akihiro Takemasa Dokkyo Medical University, Japan